Delivery Order SPE2DR25D3303-SPE2DR26F64B4
- Not listed
- The Defense Logistics Agency awarded a $1,941.36 delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 MG syringes, with an ultimate completion date of December 19, 2025. This is a firm fixed-price, non-set-aside contract executed on December 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,684.34 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed-price contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes on October 27, 2025, with a ceiling value of $2,141.05 and an ultimate completion date of October 28, 2025. This non-competitive delivery order represents a firm fixed price procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $24,305.05 by the Defense Logistics Agency on August 28, 2025, for the supply of Abilify Maintena ER 400 mg syringes. The contract is firm fixed price with an ultimate completion date of August 29, 2025, and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,256.48 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed-price, competitively awarded contract was issued on October 27, 2025, with an ultimate completion date of October 28, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This competitively awarded, firm fixed-price delivery order is set to be completed by June 30, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The contract is classified as a non-set-aside procurement, indicating it was awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This competitively awarded, firm fixed-price delivery order was issued on October 16, 2025, with an ultimate completion date of October 17, 2025. The award carries no set-aside designation, indicating open competition among qualified vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order valued at $13,697.48 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Abilify Maintena ER 400 mg vials/cartridges/syringes. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and is scheduled for completion by November 14, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,784.79 to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes, with an ultimate completion date of October 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,667.50 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 300 mg syringes, with performance at the company's corporate office location in Conshohocken, Pennsylvania. This competitive delivery order, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, carries firm fixed pricing and no set-aside designation. The contract represents a continuation of AmerisourceBergen's...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F64B4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,133.00 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. The contract, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, carries firm fixed pricing with no set-aside designation, indicating competitive award. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive portfolio of DLA contract awards demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This particular delivery order for the antipsychotic medication Abilify Maintena ER reflects the company's role in supporting Defense Health Agency operations and broader federal healthcare procurement requirements through its flexible and comprehensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/17/25 |